Gene: GMPR
Official Full Name: guanosine monophosphate reductaseprovided by HGNC
Gene Summary: This gene encodes an enzyme that catalyzes the irreversible and NADPH-dependent reductive deamination of GMP to IMP. The protein also functions in the re-utilization of free intracellular bases and purine nucleosides.[provided by RefSeq, Oct 2009]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO07398 | GMPR Knockout cell line (HCT 116) | Human | GMPR | 1:2~1:4 | Negative | Online Inquiry |
KO07399 | GMPR Knockout cell line (HEK293) | Human | GMPR | 1:3~1:6 | Negative | Online Inquiry |
KO07400 | GMPR Knockout cell line (A549) | Human | GMPR | 1:3~1:4 | Negative | Online Inquiry |
GMPR Gene Knockout Cell Lines are genetically engineered cell lines in which the Guanosine Monophosphate Reductase (GMPR) gene has been selectively disrupted. This innovative product provides researchers with a powerful tool to study the role of GMPR in various biological processes, particularly in nucleotide metabolism, cell proliferation, and immune responses. By stably knocking out the GMPR gene, these cell lines allow for the observation of the resultant phenotypic changes, thereby enabling insights into the pathways mediated by this crucial enzyme.
The mechanism of these cell lines involves the targeted deletion of GMPR, which results in the disruption of the de novo synthesis pathway of guanine nucleotides. This interruption can affect cellular proliferation rates, apoptosis, and metabolic cell states, thus providing valuable insights into conditions such as cancer and autoimmune disorders where nucleoside metabolism plays a critical role. Researchers can effectively perform functional assays, including growth characterization, drug response evaluations, and metabolic profiling, using these cell lines.
The scientific importance of GMPR Gene Knockout Cell Lines lies in their versatility in various research applications, from basic biology studies to drug discovery and therapeutic development. These knockout lines enable sophisticated experimental designs, such as the investigation of gene interactions and the effects of GMPR inhibition in a controlled environment, thus facilitating the translation of findings into clinical applications.
Compared to conventional methods of gene disruption, the GMPR Gene Knockout Cell Lines present significant advantages, such as high specificity, reliable reproducibility, and the ability to maintain the original cellular context. This ensures that findings are more relevant and applicable to in vivo situations. Additionally, these cell lines offer unprecedented ease of use, allowing researchers to save time and resources while accelerating their projects.
For researchers, clinicians, and pharmaceutical developers focused on gene function and therapeutic intervention, GMPR Gene Knockout Cell Lines represent an invaluable resource. They embody not just a tool for mechanistic exploration but also a platform for developing novel therapeutic strategies targeting nucleotide metabolism and associated disorders.
Our company specializes in the development of high-quality biological products designed to enhance research capabilities. With a strong commitment to advancing scientific understanding, we provide innovative solutions tailored to meet the needs of the research community.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.